Intellia Therapeutics, Inc. (NTLA): SCHEDULE 13G filed Aug 7, 2026

Form type

SCHEDULE 13G

Filing date

Aug 7, 2026

Accession number

0000093751-26-000484

Filer

Intellia Therapeutics, Inc. (CIK 1652130)